Journal Article DKFZ-2022-01437

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Ways to unravel the clinical potential of carbon ions for head and neck cancer reirradiation: dosimetric comparison and local failure pattern analysis as part of the prospective randomized CARE trial.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2022
BioMed Central London

Radiation oncology 17(1), 121 () [10.1186/s13014-022-02093-4]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: Carbon ion radiotherapy (CIRT) yields biophysical advantages compared to photons but randomized studies for the reirradiation setting are pending. The aim of the current project was to evaluate potential clinical benefits and drawbacks of CIRT compared to volumetric modulated arc therapy (VMAT) in recurrent head and neck cancer.Dose-volume parameters and local failure patterns of CIRT compared to VMAT were evaluate in 16 patients from the randomized CARE trial on head and neck cancer reirradiation.Despite an increased target dose, CIRT resulted in significantly reduced organ at risk (OAR) dose across all patients (- 8.7% Dmean). The dose-volume benefits were most pronounced in the brainstem (- 20.7% Dmax) and the optic chiasma (- 13.0% Dmax). The most frequent local failure was type E (extraneous; 50%), followed type B (peripheral; 33%) and type A (central; 17%). In one patient with type A biological and/or dosimetric failure after CIRT, mMKM dose recalculation revealed reduced target coverage.CIRT resulted in highly improved critical OAR sparing compared to VMAT across all head and neck cancer reirradiation scenarios despite an increased prescription dose. Local failure pattern analysis revealed further potential CIRT specific clinical benefits and potential pitfalls with regard to image-guidance and biological dose-optimization.

Keyword(s): Carbon ion radiotherapy ; Dosimetric analysis ; Head and neck cancer ; Heavy ions ; Local control ; Pattern of failure ; Re-radiotherapy ; Reirradiation ; Squamous cell carcinoma ; VMAT

Classification:

Note: #EA:E050#LA:E050#

Contributing Institute(s):
  1. E050 KKE Strahlentherapie (E050)
  2. DKTK HD zentral (HD01)
Research Program(s):
  1. 315 - Bildgebung und Radioonkologie (POF4-315) (POF4-315)

Appears in the scientific report 2022
Database coverage:
Medline ; Creative Commons Attribution CC BY (No Version) ; DOAJ ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2022-07-11, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)